Omega-3 fatty acid supplementation affects pregnancy outcomes in gestational diabetes: a randomized, double-blind, placebo-controlled trial

Double Blind Placebo ◽

Acid Supplementation ◽

Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: Randomized, double-blind, placebo-controlled trial

Clinical Nutrition ◽

10.1016/j.clnu.2014.06.005 ◽

2015 ◽

Vol 34 (3) ◽

pp. 388-393 ◽

Cited By ~ 39

Author(s):

Mansooreh Samimi ◽

Mehri Jamilian ◽

Zatollah Asemi ◽

Ahmad Esmaillzadeh

Keyword(s):

Fatty Acid ◽

Gestational Diabetes ◽

Controlled Trial ◽

Omega 3 ◽

Double Blind ◽

Insulin Metabolism ◽

Double Blind Placebo ◽

Acid Supplementation ◽

Design and methods for the Better Resiliency Among Veterans and non-Veterans with Omega-3's (BRAVO) study: A double blind, placebo-controlled trial of omega-3 fatty acid supplementation among adult individuals at risk of suicide

Contemporary Clinical Trials ◽

10.1016/j.cct.2016.02.002 ◽

2016 ◽

Vol 47 ◽

pp. 325-333 ◽

Cited By ~ 4

Author(s):

Bernadette P. Marriott ◽

Joseph R. Hibbeln ◽

Therese K. Killeen ◽

Kathryn M. Magruder ◽

Kelly Holes-Lewis ◽

...

Keyword(s):

At Risk ◽

Fatty Acid ◽

Controlled Trial ◽

Omega 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Acid Supplementation ◽

Omega 3 Fatty Acid ◽

Design And Methods

Metabolic response to omega-3 fatty acid supplementation in patients with diabetic nephropathy: A randomized, double-blind, placebo-controlled trial

Clinical Nutrition ◽

10.1016/j.clnu.2015.11.003 ◽

2017 ◽

Vol 36 (1) ◽

pp. 79-84 ◽

Cited By ~ 14

Author(s):

Alireza Soleimani ◽

Mohsen Taghizadeh ◽

Fereshteh Bahmani ◽

Negin Badroj ◽

Zatollah Asemi

Keyword(s):

Diabetic Nephropathy ◽

Fatty Acid ◽

Metabolic Response ◽

Controlled Trial ◽

Omega 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Acid Supplementation ◽

Prenatal omega-3 fatty acid supplementation does not affect offspring telomere length and F2-isoprostanes at 12 years: A double blind, randomized controlled trial

Prostaglandins Leukotrienes and Essential Fatty Acids ◽

10.1016/j.plefa.2016.08.006 ◽

2016 ◽

Vol 112 ◽

pp. 50-55 ◽

Cited By ~ 12

Author(s):

V.H.L. See ◽

E. Mas ◽

S. Burrows ◽

N.J. O’Callaghan ◽

M. Fenech ◽

...

Keyword(s):

Randomized Controlled Trial ◽

Fatty Acid ◽

Telomere Length ◽

Controlled Trial ◽

Omega 3 ◽

Double Blind ◽

Acid Supplementation ◽

Omega 3 Fatty Acid ◽

Randomized Controlled

The effects of fish oil omega-3 fatty acid supplementation on mental health parameters and metabolic status of patients with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial

Journal of Psychosomatic Obstetrics & Gynecology ◽

10.1080/0167482x.2018.1508282 ◽

2018 ◽

pp. 1-9 ◽

Cited By ~ 4

Author(s):

Mehrdad Amini ◽

Fereshteh Bahmani ◽

Fatemeh Foroozanfard ◽

Zahra Vahedpoor ◽

Amir Ghaderi ◽

...

Keyword(s):

Mental Health ◽

Fatty Acid ◽

Polycystic Ovary ◽

Controlled Trial ◽

Omega 3 ◽

Ovary Syndrome ◽

Double Blind ◽

Double Blind Placebo ◽

Effect of omega-3 (n−3) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial

American Journal of Clinical Nutrition ◽

10.3945/ajcn.112.036319 ◽

2012 ◽

Vol 97 (1) ◽

pp. 37-44 ◽

Cited By ~ 56

Author(s):

Ahmed A Daak ◽

Kebreab Ghebremeskel ◽

Zahir Hassan ◽

Bakhita Attallah ◽

Haj H Azan ◽

...

Keyword(s):

Fatty Acid ◽

Sickle Cell ◽

Sickle Cell Anemia ◽

Controlled Trial ◽

Omega 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Acid Supplementation

Faculty of 1000 evaluation for Effect of omega-3 (n-3) fatty acid supplementation in patients with sickle cell anemia: randomized, double-blind, placebo-controlled trial.

F1000 - Post-publication peer review of the biomedical literature ◽

10.3410/f.717969122.793474549 ◽

2013 ◽

Author(s):

Antonio Risitano ◽

Fabiana Perna

Keyword(s):

Fatty Acid ◽

Sickle Cell ◽

Sickle Cell Anemia ◽

Controlled Trial ◽

Omega 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Acid Supplementation

Omega-3 Fatty Acid Supplementation Improves Endothelial Function in Primary Antiphospholipid Syndrome: A Small-Scale Randomized Double-Blind Placebo-Controlled Trial

Frontiers in Immunology ◽

10.3389/fimmu.2018.00336 ◽

2018 ◽

Vol 9 ◽

Cited By ~ 4

Author(s):

Sheylla M. Felau ◽

Lucas P. Sales ◽

Marina Y. Solis ◽

Ana Paula Hayashi ◽

Hamilton Roschel ◽

...

Keyword(s):

Fatty Acid ◽

Endothelial Function ◽

Controlled Trial ◽

Small Scale ◽

Primary Antiphospholipid Syndrome ◽

Omega 3 ◽

Double Blind ◽

Double Blind Placebo ◽

An omega-3 fatty acid supplement for the treatment of hot flushes: a double-blind, placebo-controlled, randomised controlled trial

Focus on Alternative and Complementary Therapies ◽

10.1111/j.2042-7166.2007.tb05873.x ◽

2007 ◽

Vol 12 ◽

pp. 20-21

Author(s):

S Dodin ◽

M Lucas ◽

G Asselin ◽

C Merette ◽

MJ Poulin

Keyword(s):

Fatty Acid ◽

Randomised Controlled Trial ◽

Controlled Trial ◽

Hot Flushes ◽

Omega 3 ◽

Double Blind ◽

Double Blind Placebo ◽

Omega 3 Fatty Acid ◽

Fatty Acid Supplement ◽

Randomised Controlled

OT2-07-02: SWOG S0927: A Randomized Double Blind Placebo-Controlled Trial of Omega-3-Fatty Acid for the Control of Aromatase Inhibitor (AI)-Induced Musculoskeletal Pain in Women with Early Stage Breast Cancer.

10.1158/0008-5472.sabcs11-ot2-07-02 ◽

2011 ◽

Author(s):

DL Hershman ◽

JM Unger ◽

KD Crew ◽

CM Moinpour ◽

LM Minasian ◽

...

Keyword(s):

Breast Cancer ◽

Fatty Acid ◽

Aromatase Inhibitor ◽

Musculoskeletal Pain ◽

Early Stage ◽

Controlled Trial ◽

Omega 3 ◽

Double Blind ◽

Double Blind Placebo ◽